Elanco Animal Health, Inc.

Total Valuation

Elanco Animal Health, Inc. carries a market capitalization of 10.87B, placing it among publicly traded companies globally. Its enterprise value stands at 15.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Elanco Animal Health, Inc. currently has 499.38M shares outstanding.

Valuation Ratios

Elanco Animal Health, Inc. trades at a trailing price-to-earnings ratio of 275.97. The price-to-sales ratio is 2.44, and the price-to-book ratio stands at -5.61.

Enterprise Valuation

On an enterprise value basis, Elanco Animal Health, Inc. trades at an EV/EBITDA multiple of 15.62 and an EV/FCF ratio of 13.70. The EV/Sales ratio of 3.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 51.61 provides insight into valuation relative to core operating earnings.

Financial Position

Elanco Animal Health, Inc. maintains a current ratio of 2.16, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 61.40, indicating elevated leverage, while an interest coverage ratio of 4.18 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Elanco Animal Health, Inc. has paid 45.00M in income taxes, reflecting an effective tax rate of 90.48.

Stock Price Statistics

Elanco Animal Health, Inc.'s stock has gained approximately 36.34663% over the past 52 weeks. The 50-day moving average sits at 20.68, while the 200-day moving average is 19.28.

Income Statement

Over the trailing twelve months, Elanco Animal Health, Inc. generated 4.89B in revenue and converted that into -242.00M in net income, yielding earnings per share of -0.49. EBITDA reached 991.00M, while operating income came in at 300.00M.

Balance Sheet

Elanco Animal Health, Inc. holds 428.00M in cash and equivalents against 3.99B in total debt, resulting in a net debt position of 3.56B. Total book value stands at -2.12B, with working capital of 1.92B providing operational flexibility.

Cash Flow

Elanco Animal Health, Inc. produced 577.00M in operating cash flow over the past twelve months. After subtracting -262.00M in capital expenditures, free cash flow totaled 315.00M - equivalent to 0.63 per share.

Margins

Elanco Animal Health, Inc. operates with a gross margin of 55.06, reflecting its pricing power and cost economics. The operating margin of 6.13 and net profit margin of -4.95 provide insight into operational efficiency.

Dividends & Yields

Scores

Elanco Animal Health, Inc. posts an Altman Z-Score of 2.05, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.